跳至主要内容
临床试验/CTRI/2023/08/056338
CTRI/2023/08/056338已完成不适用

Tolerability, Drug Utilization Pattern and Effectiveness of Minocycline Oral Formulations in India: A Real World Retrospective Study from Electronic Medical Records

Sun Pharma Industries Ltd.1 个研究点 分布在 1 个国家目标入组 2,200 人开始时间: 2023年8月28日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
2,200
试验地点
1
主要终点
Proportion of patients with adverse events during the period of treatment with minocycline oral formulations

研究概览

简要总结

This is a retrospective, observational, real-world evidence study from Electronic Medical Records to evaluate the tolerability, drug utilization pattern and effectiveness of Minocycline Oral Formulations in India.

研究设计

研究类型
Observational

入排标准

年龄范围
12.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • Patients ≥12 years of age Patients prescribed with oral minocycline formulations Patients with a minimum of 1 follow-up visit data from the index date (first prescription) of oral minocycline formulations.

排除标准

  • Patients not on oral minocycline treatment.

结局指标

主要结局

Proportion of patients with adverse events during the period of treatment with minocycline oral formulations

时间窗: Baseline, Follow up visit

次要结局

  • Drug utilization pattern of minocycline oral formulations.(Proportion of patients with symptom resolution during the treatment period with minocycline oral formulations in acne.)

研究者

发起方
Sun Pharma Industries Ltd.
申办方类型
Pharmaceutical industry-Indian

研究点 (1)

Loading locations...

相似试验